"This mechanism has potential to be therapeutically exploited."
By Peter Hess
People who live with inflammatory bowel disease deal with a lot of physical discomfort, and for some reason cannabis
seems to give them relief. IBD, which includes conditions like
ulcerative colitis and Crohn’s disease, is an autoimmune disease,
meaning that it involves the body’s immune system mistakenly attacking
part of the body — in this case, the lining of the intestines. Patients
who use marijuana have reported that it helps with pain and discomfort,
and a few studies support this claim. But for a long time, doctors didn’t really understand what was going on.
Now, in a paper published Monday in the Journal of Clinical Investigation,
researchers from the University of Massachusetts Medical School and the
University of Bath in the United Kingdom think they know just what’s
happening on a molecular level. In a study of mice, a team of
microbiologists found that cannabinoids like those found in marijuana
appear to restore the balance that has been lost in individuals with
inflamed guts.
In a healthy gut, there’s not much inflammation, despite massive
colonies of bacteria, viruses, and yeasts, microorganisms that could
potentially trigger an inflammatory response as the body tries to get
rid of foreign invaders. At the same time, the body must be ready to
trigger such a response if the need arises. The new study’s authors note
that maintaining this balance is crucial to gut health.
“Dysregulation
of this balance can have serious consequences that may drive a variety
of pathological conditions, including inflammatory bowel disease (IBD),”
write the study’s authors. This balance involves two specific
processes. The first is the migration of cells called neutrophils across
layers of the mucous lining of the intestines. This crucial immune
process helps fight infection, but in the case of IBD, it causes the
body’s immune system to attack the intestines, causing pain and
discomfort.
The second process, involving a
protein called P-glycoprotein, halts this inflammatory response. What
the researchers found is that P-glycoprotein requires endocannabinoids
to halt the out-of-control inflammation response. Endocannabinoids,
chemicals that naturally occur in our bodies, are involved in all sorts
of processes including inflammatory responses. In the case of people
with IBD, it seems that a lack of endocannabinoids prevents the body
from maintaining homeostasis.
Therefore,
it’s possible that the relief IBD patients get when they consume
marijuana products comes from their body finally getting back into
balance.
“The
results of this study identify an important mechanism by which
endogenous endocannabinoids facilitate the resolution of inflammation,”
writes Andrew Neish, M.D., a professor of pathology at Emory University, in an invited commentary on the new study. “This mechanism has potential to be therapeutically exploited.”
And
exploiting this mechanism is exactly what the paper’s authors plan to
do. In the conflict-of-interest disclosure — a standard part of any
published research — two of the study’s authors note that they secured a
patent based on this research. So even though it’s possible that good
old-fashioned pot can help relieve the symptoms of IBD, it seems that
this research will likely aid in the development of future drugs to
treat the condition.
No comments:
Post a Comment